MERMISI LLC — Paclitaxel Importer Profile
Pharmaceutical Importer · #6 buyer for Paclitaxel · $974.5K import value · 23 shipments · GEORGIA · DGFT Verified
MERMISI LLC is the #6 importer of Paclitaxel from India with $974.5K in import value and 23 verified shipments. MERMISI LLC holds a 1.4% market share in Paclitaxel imports based in GEORGIA. The company sources from 2 verified suppliers across 12 formulations shipped to 1 country. Overall, MERMISI LLC imports 5 pharmaceutical products worth $2.3M across 3 therapeutic categories.
MERMISI LLC — Paclitaxel Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Paclitaxel to MERMISI LLC?
Verified from 23 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GETWELL PHARMA INDIA PRIVATE LIMITED | $681.3K | 15 | 69.9% |
| GETWELL PHARMACEUTICALS | $293.3K | 8 | 30.1% |
MERMISI LLC sources Paclitaxel from 2 verified Indian suppliers based on 23 customs records. The primary supplier is GETWELL PHARMA INDIA PRIVATE LIMITED accounting for 69.9% of imports.
How Does MERMISI LLC Compare to Nearest Paclitaxel Importers?
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | FRESENIUS KABI DEUTSCHLAND GMBH | GERMANY | $17.2M | 513 | $33.4K |
| 4 | J. KNIPPER & COMPANY | UNITED STATES | $1.9M | 38 | $48.9K |
| 6 | MERMISI LLC ★ | GEORGIA | $1.1M | 23 | $50.0K |
| 10 | ACCORD FARMACUTICA LTDA. | BRAZIL | $1.1M | 29 | $39.1K |
| 11 | FRESENIUS KABI COLOMBIA SAS | COLOMBIA | $1.0M | 25 | $41.7K |
MERMISI LLC ranks #6 among 959 Paclitaxel importers from India. Average shipment value of $50.0K compared to the market average of $30.0K. The closest competitors by value are FRESENIUS KABI DEUTSCHLAND GMBH and J. KNIPPER & COMPANY.
Where Does MERMISI LLC Import Paclitaxel To?
Destination countries from 23 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GEORGIA | $974.5K | 23 | 100.0% |
MERMISI LLC imports Paclitaxel to 1 country. The primary destination is GEORGIA receiving 100.0% of shipments worth $974.5K.
What Paclitaxel Formulations Does MERMISI LLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND | $517.0K | 12 |
| ALPAXEL 100MG (PACLITAXEL(PROTEIN BOUNDPARTICLES)FOR INJECTABLE SUSPENSION)B.NO.4GPNL03, MFG.DT. 04/2024,EXP DT.03/2026 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL(PROTEIN BOUND PARTICLES)FOR INJECTABLE SUSPENSION)BATCHNO.4GPNL04MFG.DT.05/2024 EXP.DT.04/26 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL(PROTEIN BOUND PARTICLES)FOR INJECTABLE SUSPENSION)BATCHNO.4GPNL05 MFG.DT.05/24EXP.DT.04/26 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL (PROTEIN BOUNDPARTICLES) FOR INJECTABLE SUSPENSION)BATCH- 5GPNL01, MFG.DT. 01/25,EXP.DT. 12/26 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL (PROTEIN BOUNDPARTICLES) FOR INJECTABLE SUSPENSION)BATCH-5GPNL02, MFG.DT. 01/25,EXP.DT. 12/26 | $50.0K | 1 |
| ALPAXEL 100MG(PACLITAXEL(PROTEIN BOUND PARTICLES)FOR INJECTABLE SUSPENSION)BATCHNO.5GPNL04,MFG.DT.02/2025,EXP.DT.01/27 | $50.0K | 1 |
| ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND PARTICLES) FOR INJECTABLE SUSPENSION) B.: 5GPNL05 M.: 02/2025 E.: 01/2027 | $50.0K | 1 |
| ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND PARTICLES) FOR INJECTABLE SUSPENSION) B.: 5GPNL06 M.: 03/2025 E.: 02/2027 | $50.0K | 1 |
| ALPAXEL 100MG PACLITAXEL PROTEIN BOUND PARTICLES FOR INJECTABLE SUSPENSION BATCH 5GPNL09 MFG DT 05 2025 EXP DT 04 2027 | $50.0K | 1 |
MERMISI LLC imports 12 distinct Paclitaxel formulations from India. The top formulation is ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND with 12 shipments worth $517.0K.
Who Are the Top Buyers of Paclitaxel from India and How Much Does MERMISI LLC Import?
India exported $28.7M worth of Paclitaxel through 4,928 shipments from 319 suppliers to 142 countries, serving 959 buyers globally. MERMISI LLC imports $974.5K of this total, accounting for 1.4% of India's Paclitaxel exports with 23 shipments from GEORGIA. This is verified from 23 customs shipment records covering 12 distinct formulations.
What Is the Average Order Value for MERMISI LLC's Paclitaxel Imports?
MERMISI LLC's average Paclitaxel order value is $42.4K per consignment, based on 23 shipments totaling $974.5K. MERMISI LLC is based in GEORGIA and ranks #6 among all Paclitaxel importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Paclitaxel to MERMISI LLC?
MERMISI LLC sources Paclitaxel from 2 verified Indian suppliers: GETWELL PHARMA INDIA PRIVATE LIMITED ($681.3K, 69.9%), GETWELL PHARMACEUTICALS ($293.3K, 30.1%). This is based on 23 customs records.
How Does MERMISI LLC Compare to Other Paclitaxel Importers?
MERMISI LLC ranks #6 among 959 Paclitaxel importers from India with a 1.4% market share. The top 3 importers are FRESENIUS KABI DEUTSCHLAND GMBH ($17.2M), J. KNIPPER & COMPANY ($1.9M), MERMISI LLC ($1.1M). MERMISI LLC processed 23 shipments from GEORGIA.
About MERMISI LLC
MERMISI LLC imports 5 products worth $2.3M. Beyond Paclitaxel, top products include Protein, Pembrolizumab, Daratumumab, Pazopanib. View the complete MERMISI LLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paclitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MERMISI LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MERMISI LLC's capped import value divided by total capped export value for Paclitaxel across all Indian exporters.
- 5.Verified Records: This page is backed by 23 individual customs records matching MERMISI LLC importing Paclitaxel, covering 12 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 142+ countries, 959+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paclitaxel Import Data for MERMISI LLC
Access order-level details, pricing data, supplier connections, and competitive analysis for MERMISI LLC's Paclitaxel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MERMISI LLC
Full Company Profile →
5 products · $2.3M total trade · 3 categories
MERMISI LLC × Paclitaxel
Verified from customs records
Company Overview
Top Products by MERMISI LLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MERMISI LLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paclitaxel. For current order-level data, contact TransData Nexus.